Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules

Radiotherapy and Oncology

Volumn 69, Issue 2, 2003, Pages 161-168

  Fowler, Jack F ^a   Harari, Paul M ^a   Leborgne, Felix ^b   Leborgne, José H ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Centro Hospitalario Pereira Rossell   (Uruguay)

Author keywords

Acute reactions; Head and neck cancer; Oral mucosa; Pharyngeal mucosa; Tolerance

Indexed keywords

ACUTE TOXICITY; CALCULATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL STIMULATION; HEAD AND NECK CANCER; HUMAN; MUCOSA INFLAMMATION; PHARYNX DISEASE; PREDICTION; PRIORITY JOURNAL; PUBLICATION; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RELIABILITY; REVIEW; STOMATITIS; TREATMENT OUTCOME;

EID: 0345304221     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00231-7     Document Type: Article

References (34)

1. Ang K.K. Altered fractionation trials in head and neck cancer. Semin Radiat Oncol. 8:(4):1998;230-236.
2. Bentzen S.M., Saunders M.I., Dische S., Bond S.J. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 60:2001;123-135.
3. Bentzen S.M., Saunders M.I., Dische S. From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change of outcome. Clin Oncol. 14:2002;372-381.
4. Bourhis J., De Crevoisier R., Abdulkarim B., et al. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 46:(5):2000;1105-1108.
5. Denekamp J., Stewart F.A., Douglas B.G. Changes in the proliferation rate of mouse epidermis after irradiation: continuous labeling studies. Cell Tissue Kinetics. 9:1976;19-29.
6. Denham J.W., Walker Q.J., Lamb D.S., et al. Mucosal regeneration during radiotherapy. Radiother Oncol. 41:1996;109-118.
7. Denham J.W., Peters L.J., Johansen J., et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol. 52:1999;157-164.
8. Denham J.W., Hauer-Jensen M. Review article: The radiotherapeutic injury - a complex 'wound'. Radiother Oncol. 63:(2):2002;129-145.
9. Dische S., Saunders M.I., Barrett A., et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
10. Dörr W., Weber-Frisch M. Repopulation response of mouse oral mucosal during unconventional radiotherapy protocols. Radiother Oncol. 37:1995;230-236.
11. Dörr W., Hendry J.H. Review article: Consequential late effects in normal tissues. Radiother Oncol. 61:2001;223-231.
12. Dörr W., Hamilton C.S., Boyd T., Reed B., Denham J.W. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys. 52:(4):2002;911-917.
13. Fowler J.F. Review article: The Linear-quadratic formula and progress in fractionated radiotherapy: A review. Br J Radiol. 62:1989;679-694.
14. Fowler J.F. Repair between dose fractions: a simpler method of analyzing and reporting apparently biexponential repair. Radiat Res. 158:2002;141-151.
15. Fu K.K., Pajak T.F., Trotti A., et al. Radiation Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and squamous cell carcinomas: First report of RTOG 90-03. Int J Radiat Oncol Biol Phys. 48:2000;7-16.
16. Harari P.M., Mehta M.P., Ritter M.A., Petereit D.G. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors. Semin Radiat Oncol. 13:(1):2003;3-12.
17. Hegazy M.A.H., Fowler J.F. Cell population kinetics and desquamation skin reactions in plucked and unplucked mouse skin II. Irradiated skin. Cell Tissue Kinetics. 6:1973;587-602.
18. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loc-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 44:1997;111-121.
19. Jackson S.M., Weir L.M., Hay J.H., et al. randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 43:1997;39-46.
20. Kaanders J.H.A.M., van der Kogel A.J., Ang K.K. Altered fractionation: limited by mucosal reactions? Radiother Oncol. 50:1999;247-260.
21. Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neckRadiother Oncol 1985;4:1-7.
22. Lamb D.S., Denham J.W., Morum P.E., Gray A.J. Long-term results of accelerated treatment for advanced head and neck cancer. Radiother Oncol. 49:1998;29-32.
23. Leborgne F., Leborgne J.H., Fowler J., Zubizarreta E., Mezzera J. Accelerated hyperfractionated irradiation for advanced head and neck cancer: effect of shortening the median treatment duration by 13 days. Head Neck. 23:(8):2001;661-668.
24. Maciejewski B., Skladowski K., Pilecki B., et al. Randomized clinical; trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol. 40:1996;137-145.
25. MacKenzie R., Balogh J., Choo R., et al. Accelerated radiotherapy with delayed comcomitant boost in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 45:(3):1999;589-595.
26. Morris G.M. Review article: Effects of radiation on the cell proliferation kinetics of epithelial tissues - therapeutic implications. Br J Radiol. 69:1996;795-803.
27. McGinn C.J., Harari P.M., Fowler J.F., et al. Intensification in curative head and neck cancer radiation therapy: Linear quadratic analysis and preliminary assessment of clinical results. Int J Radiat Oncol Biol Phys. 27:1993;363-369.
28. O'Sullivan J.M., Hollywood P.D., Cody N., Dillon J., et al. Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer - a feasibility study. Clin Oncol (R Coll Radiol UK). 14:2002;236-240.
29. Overgaard J., Hansen H.S., Overgaard M., et al. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - Report from the DAHANCA 7 trial [abstract]. Int J Radiat Oncol Biol Phys. 39:(Suppl. 2):1997;188.
30. Skladowski K., Maciejewski B., Golen M., Pilecki B., Przeorek W., Tarnawski R. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity. Radiother Oncol. 55:2000;101-110.
31. Slevin N.J., Hendry J.H., Roberts S.A., et al. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol. 24:1992;215-220.
32. Wang C.C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys. 14:1988;1143-1146.
33. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
34. Zackrisson B., Franzen L., Henriksson R., Littbrand B. Tolerance to accelerated fractionation in the head and neck region. Acta Oncol. 33:(4):1994;391-396.